Tema Cardiovascular and Metabolics ETF (HRTS) Institutional Ownership $34.93 +0.16 (+0.46%) (As of 02:37 PM ET) Add Compare Share Share OwnershipStock AnalysisChartHeadlinesHoldingsOwnershipRatingsShort InterestTrendsStock AnalysisChartHeadlinesHoldingsOwnershipRatingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS)Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$871.17KNumber ofInstitutional Sellers(last 12 months)0 Get HRTS Insider Trade Alerts Want to know when executives and insiders are buying or selling Tema Cardiovascular and Metabolics ETF stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad Monetary GoldBiden's Executive Order, Dems Digital Money Legislation, First Step ToDonald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.This means you must act NOW before it's too late. Tema Cardiovascular and Metabolics ETF Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/5/2024 Sterling Investment Advisors Ltd.153,090$5.10M1.4%+20.6%6.027% (Data available from 1/1/2016 forward) HRTS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of HRTS shares? During the previous two years, the following institutional investors and hedge funds held shares of Tema Cardiovascular and Metabolics ETF shares: Sterling Investment Advisors Ltd. ($5.10M).Learn more on HRTS's institutional investors. Which institutional investors have been buying Tema Cardiovascular and Metabolics ETF stock? The following institutional investors have purchased Tema Cardiovascular and Metabolics ETF stock in the last 24 months: Sterling Investment Advisors Ltd. ($26.13K). How much institutional buying is happening at Tema Cardiovascular and Metabolics ETF? Institutional investors have bought a total of 26,130 shares in the last 24 months. This purchase volume represents approximately $871.17K in transactions. Related Companies: FDIF Major Shareholders ENTR Major Shareholders FDIG Major Shareholders GNOM Major Shareholders SARK Major Shareholders FBOT Major Shareholders EMXF Major Shareholders LEGR Major Shareholders WCBR Major Shareholders SPC Major Shareholders This page (NASDAQ:HRTS) was last updated on 9/16/2024 by MarketBeat.com Staff From Our PartnersMore Than 30 Federal Agencies Buy From This Cybersecurity TechIn January of 2022 Ukraine was hit by an especially nasty piece of malware, named WhisperGate. By then Ukra...Capital Trends | Sponsored44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredBREAKING NEWS: AI Tech Now Used to Stop School ShootersTwo seconds. That's all it takes for Knightscope's Automated Gunshot Detection to notify authorities and map a...Market JAR | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredNvidia needs these 3 companies on a new $1 trillion SuperprojectNvidia is pivoting to a new $1 trillion Superproject that could revolutionize the AI industry… again. And i...Weiss Ratings | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredWhy Institutions Are Bullish on BitcoinThe recent dip in the crypto market might be stressful… But it also presents a tremendous opportunity for s...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Cardiovascular and Metabolics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Cardiovascular and Metabolics ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.